Baltimore (Dec. 15, 2025) – Chase Brexton’s substance use treatment clinic will expand access to additional patients in Baltimore City thanks to a recent grant from Maryland’s Office of Overdose Response (MOOR).
Since its establishment in January 2024, Chase Brexton’s Substance Use Treatment Enhancement Program (STEP) Clinic has provided Medications for Opioid Use Disorders (MOUD), harm reduction services, and peer recovery support to populations impacted by the Opioid Epidemic in Baltimore City and surrounding areas.
With the support from MOOR, Chase Brexton will expand the STEP Clinic to include a dedicated substance use order RN, who will enhance services provided during clinic such as long-acting injectable buprenorphine. This nurse will also coordinate participants’ care across Chase Brexton service lines and disciplines, and provide harm reduction services and treatment adherence support.
Chase Brexton will also use the state funding to increase the number of STEP Clinic sessions, including scheduled and Open Access appointments. These additional sessions will improve access to opioid use disorder medication as well as additional services, such as peer recovery support provided by a Certified Peer Recovery Specialist (CPRS), screening and treatment services for other substance use related conditions, naloxone and naloxone training, and linkage to primary care and behavioral health.
News